Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study


Autoria(s): Obreli-Neto, Paulo Roque; Nobili, Alessandro; Baldoni, Andre de Oliveira; Guidoni, Camilo Molino; de Lyra Junior, Divaldo Pereira; Pilger, Diogo; Duzanski, Juliano; Tettamanti, Mauro; Cruciol-Souza, Joice Mara; Gaeti, Walderez Penteado; Nakamura Cuman, Roberto Kenji
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

05/11/2013

05/11/2013

2012

Resumo

Although the prevalence of drug-drug interactions (DDIs) in elderly outpatients is high, many potential DDIs do not have any actual clinical effect, and data on the occurrence of DDI-related adverse drug reactions (ADRs) in elderly outpatients are scarce. This study aimed to determine the incidence and characteristics of DDI-related ADRs among elderly outpatients as well as the factors associated with these reactions. A prospective cohort study was conducted between 1 November 2010 and 31 November 2011 in the primary public health system of the Ourinhos micro-region, Brazil. Patients aged a parts per thousand yen60 years with at least one potential DDI were eligible for inclusion. Causality, severity, and preventability of the DDI-related ADRs were assessed independently by four clinicians using validated methods; data were analysed using descriptive analysis and multiple logistic regression. A total of 433 patients completed the study. The incidence of DDI-related ADRs was 6 % (n = 30). Warfarin was the most commonly involved drug (37 % cases), followed by acetylsalicylic acid (17 %), digoxin (17 %), and spironolactone (17 %). Gastrointestinal bleeding occurred in 37 % of the DDI-related ADR cases, followed by hyperkalemia (17 %) and myopathy (13 %). The multiple logistic regression showed that age a parts per thousand yen80 years [odds ratio (OR) 4.4; 95 % confidence interval (CI) 3.0-6.1, p < 0.01], a Charlson comorbidity index a parts per thousand yen4 (OR 1.3; 95 % CI 1.1-1.8, p < 0.01), consumption of five or more drugs (OR 2.7; 95 % CI 1.9-3.1, p < 0.01), and the use of warfarin (OR 1.7; 95 % CI1.1-1.9, p < 0.01) were associated with the occurrence of DDI-related ADRs. With regard to severity, approximately 37 % of the DDI-related ADRs detected in our cohort necessitated hospital admission. All DDI-related ADRs could have been avoided (87 % were ameliorable and 13 % were preventable). The incidence of ADRs not related to DDIs was 10 % (n = 44). The incidence of DDI-related ADRs in elderly outpatients is high; most events presented important clinical consequences and were preventable or ameliorable.

Fundacao de Apoio ao Desenvolvimento Cientifico (FADEC)

Fundacao de Apoio ao Desenvolvimento Cientifico (FADEC)

Identificador

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, HEIDELBERG, v. 68, n. 12, supl. 1, Part 2, pp. 1667-1676, DEC, 2012

0031-6970

http://www.producao.usp.br/handle/BDPI/41458

10.1007/s00228-012-1309-3

http://dx.doi.org/10.1007/s00228-012-1309-3

Idioma(s)

eng

Publicador

SPRINGER HEIDELBERG

HEIDELBERG

Relação

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Direitos

closedAccess

Copyright SPRINGER HEIDELBERG

Palavras-Chave #DRUG INTERACTIONS #DRUG TOXICITY #AGE #OUTPATIENTS #COHORT STUDIES #PHARMACOVIGILANCE #NONSTEROIDAL ANTIINFLAMMATORY DRUGS #IN-HOSPITAL INPATIENTS #DIGITALIS GLYCOSIDES #MANIFESTATIONS #HYPERKALEMIA #PREVALENCE #MECHANISMS #RELEVANCE #TOXICITY #THERAPY #PHARMACOLOGY & PHARMACY
Tipo

article

original article

publishedVersion